The first-of-its-kind respiratory syncytial virus vaccine developed by artificial intelligence has shown good results.
The FDA has granted an orphan status to MIV-818 a new hepatocellular carcinoma drug manufactured by a small biotech company.
According to scientists, the new drug is chemically aggressive and it is able to get inside the cells and destroy tuberculosis bacteria.
Experts hope that the simple procedure will become standard for middle-aged people who are at risk of developing such disease.
Colorectal cancer is one of the most common cancer pathologies in both men and women. The risk of developing is 4.2% and 4.5% in women and men, respectively.
The therapy is much better tolerated by cancer patients taking a placebo openly than those from the control group that did not receive any additional tablets.
Scientists have revealed the reduction of the number of cancer polyps due to activity of eicosapentaenoic acid.
A study by Chinese scientists has shown that increased magnesium content in the diet of adult patients helps to reduce the risk of developing type 2 diabetes. In addition it helps to improve insulin resistance in patients with type 2 diabetes.
According to a recent global study by French scientists, infections are the reason for 13% of all new cancer diagnoses.